Yuejuan Cheng Selected Research

Yuejuan Cheng Research Topics

15	Neoplasms (Cancer) 02/2024 - 01/2018
13	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2023 - 03/2016
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 03/2019
4	Neoplasm Metastasis (Metastasis) 11/2020 - 01/2019
3	Adenocarcinoma 10/2023 - 12/2022
2	Microsatellite Instability 01/2023 - 01/2020
2	Diarrhea 01/2022 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 07/2021 - 01/2019
2	Disease Progression 07/2021 - 11/2020
2	Lymphatic Metastasis 01/2021 - 01/2020
2	Hypertension (High Blood Pressure) 11/2020 - 01/2019
2	Proteinuria 11/2020 - 01/2019
1	Acinar Cell Carcinoma 12/2023
1	Neutropenia 12/2022
1	Dyspnea (Shortness of Breath) 01/2022
1	Thrombosis (Thrombus) 11/2020
1	Carcinogenesis 01/2020
1	Hyperuricemia 01/2019
1	Hypertriglyceridemia 01/2019
1	Cushing Syndrome 01/2019

4	surufatinibIBA 01/2023 - 01/2019
3	gallium Ga 68 dotatateIBA 01/2022 - 01/2020
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022 - 11/2018
2	Gemcitabine FDA Link 01/2023 - 12/2022
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
1	Gallium-68IBA 02/2024
1	Somatostatin Receptors (Somatostatin Receptor)IBA 02/2024
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2023
1	trametinibIBA 10/2023
1	130-nm albumin-bound paclitaxelIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 07/2021
1	Radioisotopes (Radionuclides)IBA 01/2021
1	Peptide Receptors (Peptide Receptor)IBA 01/2021
1	Evans Blue (Blue, Evans)FDA Link 01/2020
1	LigandsIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Versicans (Versican)IBA 01/2020
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 03/2019
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	Circulating Tumor DNAIBA 01/2019
1	lutetium Lu 177 dotatateIBA 11/2018
1	Peptides (Polypeptides)IBA 11/2018
1	Chromogranin AIBA 03/2016

7	Therapeutics 10/2023 - 01/2018
6	Drug Therapy (Chemotherapy) 06/2023 - 01/2019
3	Neoadjuvant Therapy 01/2024 - 06/2023
2	Adjuvant Chemotherapy 12/2022 - 03/2019
1	Thrombectomy 12/2023
1	Pancreatectomy 12/2023
1	Immunotherapy 01/2023
1	Palliative Care (Palliative Therapy) 12/2022
1	Combined Modality Therapy 11/2019
1	Salvage Therapy 03/2019
1	Aftercare (After-Treatment) 01/2018